XJPX
3401
Market cap2.00bUSD
Oct 09, Last price
1,640.50JPY
1D
0.00%
1Q
-1.32%
Jan 2017
-30.75%
Name
Teijin Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Teijin Limited, a global enterprise established in Tokyo, Japan, in 1918, operates across multiple key sectors including fibers, films, composites, healthcare, and IT. The company's advanced materials portfolio encompasses various fibers such as aramid, carbon, and polyester, alongside specialized films like polycarbonate and high-density polyethylene. It also produces resins, molded parts, and additives, as well as lightweight glass and carbon fiber reinforced composites, particularly for automotive applications. In the healthcare domain, Teijin develops pharmaceuticals addressing a range of conditions, including bone and joint, respiratory, and cardiovascular diseases. It further provides medical devices for home oxygen therapy, non-invasive ventilation, rehabilitation, and sleep disorders, complemented by orthopedic implants and functional food ingredients. Beyond materials and healthcare, Teijin offers IT solutions like Recopic, an RFID technology for inventory management. The company also leverages its engineering expertise to address global issues such as environmental pollution, energy supply stability, and challenges associated with an aging workforce population.
Related entities
Subsidiaries (3)
Teijin Carbon Europe GmbH
Teijin Holdings Europe B.V.
Teijin Aramid B.V.
Key people
Naohiko Moriyama
Chief Financial Officer, Senior Managing Executive Officer, Representative Director · since 2024
Eiji Ogawa
Senior Managing Executive Officer of Teijin Group · since 2024
Noboru Yamanishi
Managing Executive Officer, Director · since 2023
Masataka Akiyoshi
Executive Officer of Teijin Group, Chief Director of Composite Molding Materials Business · since 2024
Noriko Higuchi
Executive Officer of Teijin Group, Chief Director of New Corporate Business · since 2024
Yasunari Hirata
Executive Officer of Teijin Group, Chief Director of Healthcare Business, President of Subsidiary · since 2024
Peter Horst
Executive Officer of Teijin Group, Chief Director of Aramid, President of Subsidiary · since 2024
Tsutomu Igawa
Executive Officer of Teijin Group · since 2024
Shukei Inui
Executive Officer of Teijin Group, Chief Director of Carbon Fiber Business · since 2024
Junji Kitahama
Executive Officer of Teijin Group, Chief Director of Resins Business · since 2024
Yasuhiko Kuriyama
Executive Officer of Teijin Group · since 2024
Fumiaki Sakurai
Executive Officer of Teijin Group · since 2024
Masato Tanaka
Executive Officer of Teijin Group · since 2024
Masaki Taneda
Executive Officer of Teijin Group, Chief Director of Healthcare Business, President of Subsidiary · since 2024
Akimoto Uchikawa
Executive President, Chief Executive Officer, Representative Director · since 2022
Reiko Kusunose
Independent Director · since 2024
Tamie Minami
Independent Director · since 2023
Masaru Onishi
Independent Director · since 2019
Independent Director · since 2022
Headquarters & legal address
中之島三丁目2番4号
大阪府 大阪市北区 530-8605
JP
大阪府 大阪市北区 530-8605
JP
Address
2-4, Nakanoshima 3-chome
Kita-ku Osaka 530-8605
JP
Kita-ku Osaka 530-8605
JP
Other language
TEIJIN LIMITED
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||